Home
Captor Therapeutics

Captor Therapeutics Market Share Analysis for May 2026

captor therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome.

Industry: N/A

Domaincaptortherapeutics.com

Year Founded2017

Employees51 - 200

Annual Revenue$5M - $10M

Captor Therapeutics

Captor Therapeutics (including company regionals)

captortherapeutics.com

See more website traffic and engagement information

Captor Therapeutics Revenue up to May 2026 is 5M - 10M

revenue generated by Captor Therapeutics top domains

Captor Therapeutics top domains revenue over 3 years

Revenue for Captor Therapeutics top domains

captortherapeutics.com5M - 10M

See more with Sales Intelligence

Total visits to Captor Therapeutics's top domains

Understand Captor Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

captortherapeutics.com3.2K

See more with Sales Intelligence

Avg. visit duration in Captor Therapeutics's top domains

Analyze Captor Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

captortherapeutics.com00:00:05

See more with Sales Intelligence

Avg. pageviews on Captor Therapeutics's top domains

See how Captor Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

captortherapeutics.com1.63

See more with Sales Intelligence

Captor Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Captor Therapeutics

These are the website technologies, by industry, used by Captor Therapeutics top domains

Content Management System (2)

Joomla

Email Services (2)

G Suite

Advertising (1)

PubMatic

Audio Video Media (1)

YouTube

More Technologies

6

See all

News & Signals from Captor Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCaptor Therapeutics Inc is developing small molecule protein degraders on Nov 1st '22.Ono Pharmaceutical and Captor announced in November 2022 a drug discovery collaboration to develop small molecule protein degraders for the treatment of neurodegenerative diseases.

NewsCaptor Therapeutics Inc is developing novel small molecule degrader drugs.Captor Therapeutics S.A. (WSE: CTX), a leader in the development of Targeted Protein Degradation (TPD)-based drugs, today announces a worldwide drug discovery collaboration with Ono Pharmaceutical Co., Ltd. (Ono), to develop novel small molecule degrader drugs against a currently undrugged target of interest in neurodegenerative diseases.

NewsCaptor Therapeutics Inc hires Michał Walczak as Chief Scientific Officer of Captor Therapeutics.Captortherapeutics is consistently investing in the development of its R&D capabilities and laboratories and hiring experienced specialists who want to take part in the development of its projects - comments Dr. Michał Walczak, Member of the Board and Chief Scientific Officer of Captor Therapeutics.